Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
7.57
+0.20 (2.71%)
Jan 9, 2026, 1:48 PM EST - Market open
Cybin Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
50
Market Cap
377.77M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | 686.88K | - | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
HELP News
- 9 days ago - Cybin Initiates At-The-Market Equity Program of up to US$100 Million - Business Wire
- 22 days ago - Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq - Business Wire
- 2 months ago - Cybin Inc. (CYBN) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights - Business Wire
- 2 months ago - Cybin to Participate in the Jefferies Global Healthcare Conference in London - Business Wire
- 2 months ago - Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025 - Business Wire
- 2 months ago - Cybin to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference - Business Wire
- 2 months ago - Cybin to Participate at the 2025 Milken Institute Future of Health Summit - Business Wire